In this context, TNF-α inhibitors were found to halt depigmentation, but while the activity of vitiligo can be controlled with TNF-α inhibition, real-life data do not support a correlation between disease duration prior to anti-TNF-α exposure and treatment efficacy [33]. This evidence concerns the gene TNF and vitiligo.